Loading…

Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice

Loss of imprinting (LOI) of the insulin-like growth factor II gene (IGF2) is an epigenetic alteration that results in a modest increase in IGF2 expression, and it is present in the normal colonic mucosa of about 30% of patients with colorectal cancer. To investigate its role in intestinal tumorigene...

Full description

Saved in:
Bibliographic Details
Published in:Science (American Association for the Advancement of Science) 2005-03, Vol.307 (5717), p.1976-1978
Main Authors: Sakatani, Takashi, Kaneda, Atsushi, Iacobuzio-Donahue, Christine A, Carter, Mark G, de Boom Witzel, Sten, Okano, Hideyuki, Ko, Minoru S. H, Ohlsson, Rolf, Longo, Dan L, Feinberg, Andrew P
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Loss of imprinting (LOI) of the insulin-like growth factor II gene (IGF2) is an epigenetic alteration that results in a modest increase in IGF2 expression, and it is present in the normal colonic mucosa of about 30% of patients with colorectal cancer. To investigate its role in intestinal tumorigenesis, we created a mouse model of Igf2 LOI by crossing female H19[superscript +/-] mice with male Apc[superscript +/Min] mice. Mice with LOI developed twice as many intestinal tumors as did control littermates. Notably, these mice also showed a shift toward a less differentiated normal intestinal epithelium, reflected by an increase in crypt length and increased staining with progenitor cell markers. A similar shift in differentiation was seen in the normal colonic mucosa of humans with LOI. Thus, altered maturation of nonneoplastic tissue may be one mechanism by which epigenetic changes affect cancer risk.
ISSN:0036-8075
1095-9203
DOI:10.1126/science.1108080